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Abstract 
Background: Chronic kidney disease (CKD) is a global public health problem, with a greater burden and prohibitive cost of care particularly in 
developing countries. This study determined the prevalence of chronic kidney disease and identified its associated risk factors in patients attending 
the Family Practice Clinic, Wesley Guild Hospital, Ilesa, Nigeria. 
Method: Consecutive newly-registered patients who attended the Family Practice Clinic of Wesley Guild Hospital, Ilesa from August 2005 to January 
2006 were recruited and studied. Relevant data were collected by using an interviewer-administered questionnaire, and determining the spot urinary 
ACR (albumin-creatinine ratio) of the subjects by using Microalbustix™ reagent strips and using their serum creatinine concentration. The glomerular 
filtration rate (GFR) of each subject was estimated using the Modification of Diet in Renal Disease (MDRD) formula. A repeat urine test was done three 
months after the initial screening to identify subjects with persistent microalbuminuria.
Results: The age of the study subjects ranged from 20 to 74 years, with a mean age of 50.52 + 13.03 years. There were 68 males and 182 females in 
the sample population, showing a male to female ratio of 1:2.7. One hundred and thirteen of the 250 subjects (45.2%) were found to have pathologic 
albuminuria at the initial screening, while 31 (12.4%) had persistent albuminuria three months later. Also, 51 subjects (20.4%) had estimated low 
GFR at the initial screening and 26 (10.4%) had persistent low GFR three months later. Significant risk factors for CKD in the study subjects were 
increasing age, elevated blood pressure, history of diabetes mellitus (DM), habitual intake of analgesics and herbs, and an abnormal waist to hip ratio 
(p < 0.05). The association between persistent abnormal ACR and low GFR did not reach statistical significance (p = 0.053). Habitual analgesic intake 
(p = 0.002) and age group (p = 0.0027) were true predictors of CKD among the study subjects. 
Conclusions: The prevalence of CKD in the study population was high and its association with modifiable risk factors was demonstrated. Family 
physicians have a unique opportunity to identify and address these factors in their patients. Routine screening for CKD in family practice clinics is 
indicated to reduce the burden of renal disease in the population. 
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Introduction
The kidneys are vital excretory organs and are central to fluid, electrolyte 
and acid-base homeostasis in humans.1 Damage of the kidneys has 
serious implications for systemic functions, growth and existence. 
Irreversible damage that compromises the ability of the kidneys to 
sustain bodily functions, normal growth and life as occurs in end stage 
renal disease poses great challenges of renal replacement strategies 
and other management modalities.1 
World Health Organization (WHO) statistics reveal that the death rate 
from intrinsic kidney and urinary tract disease was one million in the 
year 2002, ranking twelfth on the list of major causes of death.2 The 
prevalence of chronic kidney disease (CKD) in the community was grossly 
underestimated in the past. The prevalence of impaired kidney function 
was estimated to range between 10% and 20% of the adult population in 
most countries worldwide.2,3 However, a recent study suggests that the 
incidence of CKD is increasing globally.4 The National Kidney Foundation 
estimates that 20 million Americans have chronic kidney disease and at 
least a further 20 million people have an increased risk.4,5 
In developing countries like Nigeria, the prevalence of preventable 
renal diseases is not known. Akinsola et al. reported that renal failure 
constituted 8% of hospital admissions.6 However, Abioye-Kuteyi et al. 
reported a prevalence of 19.9% of undetected renal diseases in a rural 
populace in Nigeria,7 while Nwankwo et al. reported an incidence of 
45.5% of impaired kidney function among hospitalised hypertensive 
patients in Maiduguri.8 
In sub-Saharan Africa, and indeed also in Nigeria, hypertension and 
diabetes mellitus are among the leading causes of end-stage renal 
disease.9 By 2020, the burden of diabetes and cardiovascular disease 
will have increased by 130% in Africa alone, with concomitant increases 
in the prevalence of CKD and end-stage renal disease (ESRD).10
According to the definition provided by the Kidney Disease Outcome 
Quality Initiative (K/DOQI),4 the presence of chronic kidney disease 
should be established based on the occurrence of kidney damage and 
the level of kidney function, regardless of the specific diagnosis of 
diseases and conditions causing the damage. The diagnosis of chronic 
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kidney disease is based on the evidence of kidney damage and/or 
reduced kidney function lasting at least three months.4,5 Initial evidence 
of kidney damage or a reduction in kidney function can be detected 
through routine blood or urine testing. The most common indicators of 
kidney damage are proteins in the urine (proteinuria or albuminuria), 
blood in the urine (haematuria) and raised levels of urea or creatinine 
(a waste product of protein metabolism) in the blood.1,2 However, the 
reliable marker of kidney damage is the persistence of albumin in the 
urine.2 The ratio of albumin to creatinine (ACR) obviates the need for 
24-hour urine collection to assess proteinuria, and it correlates well 
with kidney function.11 In resource-poor countries like Nigeria, this is a 
useful screening tool to detect CKD, especially in family practice clinics. 
Furthermore, there is sparse information on the magnitude of CKD in this 
environment, hence this study aimed to determine the prevalence of CKD 
and to identify associated risk factors in the Nigerian adult population. 
Patients and methods
This was a cross-sectional study of incidental screening for CKD in 
patients attending the Family Practice Clinic of the Wesley Guild Hospital 
Unit (WGH) of the Obafemi Awolowo University Teaching Hospitals 
Complex (OAUTHC) in Ilesa, south-west Nigeria. Although the clinic is 
situated within a teaching hospital, it offers primary care services and 
operates a ‘walk-in’ policy, as no referrals are required before patients 
are attended to.
Sampling method
The study was carried out in three stages. In the first stage, newly 
registered patients in the clinic were selected consecutively and requested 
to undergo urine microscopy. The questionnaire was administered to 
subjects who qualified for the second stage of the study, and they also 
underwent urine and blood testing. In the third stage, subjects with 
albuminuria had to undergo repeat blood and urine testing three months 
after the initial testing to determine those with persistent albuminuria.
Ethics clearance and consent
Ethics clearance was obtained from the OAUTHC Research and Ethical 
Committee. Informed written consent was obtained from each subject. 
Confidentiality and privacy were ensured by not indicating the names of 
the subjects on the questionnaire, and only the investigators had access 
to the data. 
Instruments
Data were collected using the following instruments (this section was 
rearranged in chronological order):
i)  A semi-structured, interviewer-administered questionnaire. The 
socio-demographic information of each subject was collected, and 
the past medical history of hypertension, diabetes mellitus and 
renal diseases was obtained. Current history of nocturia, dysuria, 
haematuria, frothiness of urine and facial/leg swelling was obtained. 
A family history of hypertension and diabetes mellitus was also 
taken. Other information sought in the questionnaire consisted of 
cigarette smoking, alcohol intake, analgesics use, use of herbal 
concoctions, as well as the frequency, dosage and duration of use of 
these substances. Analgesics that were enquired about specifically 
included aspirin-containing preparations, indocid, butazolidin and 
paracetamol. For the purpose of this study, analgesic abuse was taken 
as a cumulative lifetime use of more than 5 000 pills of analgesics.12 
This was calculated from multiplying the average number of pills 
consumed in a week by the duration of use in years.12 Smoking 20 
cigarettes daily for more than one year was considered significant, 
while the consumption of ≥ 60 g of alcohol in a week by men and 
≥ 30 g by women was taken as significant.
ii)  Bayer Microalbustix™ reagent strips for determining the albumin-
creatinine ratio in the urine [serial number: 04960872; patent number: 
5187104]. Freshly voided spot mid-stream urine was collected from 
each consenting subject and sent for microscopy. Any subject with 
more than two white blood cell counts per high-power field in the 
urine was excluded from the study. The spot urine of subjects eligible 
for the second stage of the study was tested with Microalbustix™ 
reagent strips according to the specified procedure. A repeat urine 
test with the same reagent strip was carried out at three months for 
subjects who had initial albuminuria.
iii)  A stadiometer was used to measure the height of the subjects, while 
the weight of each subject was measured to the nearest 500 g using 
a weighing scale (Waymaster Model, patent pending in England). The 
body mass index [BMI = weight/height2] was calculated for subjects. 
They were classified using the WHO classification of obesity.13 
Overweight was regarded as a BMI of between 25 and 29.9 kg/m2, 
while obesity was taken as a BMI greater than 30 kg/m2. 
iv)  The resting blood pressure of each subject was measured with an 
Accosson® mercury sphygmomanometer using standard techniques. 
Elevated blood pressure was taken as being equal to or greater than 
140/90 mmHg.
vi)  A non-stretching tape was used to measure the waist circumference 
of each subject at the level of the umbilicus, and the hip circumference 
at the level of the greater trochanter. The waist-to-hip ratio (WHR) 
was calculated for each subject. Abdominal obesity was taken as a 
WHR > 0.9 in males and > 0.85 in females.
v)  A stopwatch was used to time the readings of the albumin and 
creatinine tests. The albumin test was read at 50 seconds after 
dipping and the creatinine test at 60 seconds, and then the albumin-
creatinine (ACR) ratio was calculated.
The serum creatinine concentration of all the subjects was analysed by 
using the standard spectrometric method. The value of serum creatinine 
obtained from the laboratory was used to calculate the glomerular 
filtration rate (GFR) of each subject, using the modified MDRD formula: 
GFR = 186 x (Cr)-1.154 x (Age)-0.203 x 0.742 (if female) x 1.210 
(if black).5 
Subjects with an estimated GFR of less than 60 ml/min/1.73m2 at the 
first visit underwent a repeat serum creatinine test at three months 
and the GFR was re-estimated according to NKF diagnostic criteria for 
CKD.4,5 All the subjects with persistent GFR < 60 mL/min/1.73m2 were 
classified as having CKD, irrespective of the presence or absence of 
kidney damage. The rationale for including these individuals is that a 
reduction in kidney function to this level of GFR or lower represents a 
loss of half or more of the adult level of normal kidney function, which 
may be associated with a number of complications.5 Subjects who had 
albuminuria at the first visit underwent a repeat albumin-creatinine ratio 
(ACR) test at three months. Subjects with persistent abnormal ACR were 
classified as having CKD, irrespective of the level of GFR. The rationale 
for including subjects with a GFR ≥ 60 mL/min/1.73 m2 is that GFR may 
be sustained at normal or increased levels despite substantial kidney 
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damage, and these subjects are at increased risk of the two major 
outcomes of chronic kidney disease, namely loss of kidney function and 
development of cardiovascular disease.5 
Interpretation of urinary albumin and creatinine 
tests11
Albumin-to-creatinine ratio
An albumin level of less than 30 mg albumin/g creatinine (3.4 mg 
albumin/mmol creatinine) was regarded as representing a normal 
ACR. Microalbuminuria is indicated at a ratio of 30 to 300 mg/g (3.4 to 
33.9 mg/mmol) (abnormal ACR), and clinically overt albuminuria at a ratio 
of > 300 mg/g (> 33.9 mg/mmol) was regarded as macroalbuminuria. 
Exclusion criteria
Subjects who had undergone strenuous exercise, those with urinary 
tract infections or acute illness with fever, and those who refused to 
give consent were excluded from the study. Subjects who were on ACE 
inhibitors prior to the study were also excluded from the study.
Data analysis
All data collected were fed into a computer and analysed using the 
Statistical Package for Social Sciences (SPSS) for Windows software 
version 11.14 Means, modes, medians, standard deviations and 
proportions were determined as applicable. The proportions and ratios 
were compared using the Pearson’s Chi squared (χ2) test. A p value 
equal to or less than 0.05 was taken as statistically significant.
Results
Out of 1 250 patients recruited in the first stage of the study, 250 
participated in the second stage, while 113 subjects underwent repeat 
blood and urine testing in the third stage of the study. The mean age 
of the respondents was 50.52 ± 13.03 years, and the median age was 
53.0 years. Their socio-demographic characteristics are shown in Table I. 
Table I shows that the majority of the study subjects were 45 years 
and older (70.4%), female (72.8%) and of Christian faith (90.8%). 
It also shows that the majority of subjects were married (76.8%) and that 
67.6% were self-employed.
Figure 1 shows that 54.8% of the 250 subjects had normoalbuminuria, 
111 (44.4%) had microalbuminuria and two (0.8%) had macroalbuminuria 
at the initial screening.  
Figure 2 shows that 28% of 113 subjects had persistent albuminuria, in 
contrast to 45.2% who had albuminuria at the initial screening.
Table I: Socio-demographic distribution of study subjects 
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Figure 1: Bar chart showing distribution of study subjects by urinary ACR at
















Figure 2: Pie chart showing distribution of subjects with persistent urinary
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Table II shows that 51 subjects (20.4%) had a low GFR at the initial 
screening, compared to 26 (50.9%) who had persistent low GFR at three 
months.
As shown in Table III, 22 subjects (61.1%) with persistent albuminuria 
had a persistent low GFR. However, this did not reach statistical 
significance. 
Table IV shows that there is a significant association between abnormal 
ACR and age above 55 years, elevated systolic blood pressure, elevated 
diastolic blood pressure, history of diabetes mellitus (DM), habitual use 
of analgesic and herbal medications, as well as abnormal waist-to-hip 
ratio, while gender, BMI, family history of HT/DM, alcohol intake and 
cigarette smoking were not significantly associated with abnormal ACR 
in the study subjects.
Table V shows that habitual analgesic intake and the age of the subjects 
are strong predictors of abnormal ACR in the study subjects.
Discussion
In this study, 10.4% of the subjects had a persistent low GFR, compared 
to 12.4% with persistent albuminuria. There is overwhelming evidence 
that microalbuminuria is a reliable marker of kidney damage because 
it is detected much earlier than an increase in serum creatinine in 
CKD.4,5 However, both figures are similar to 11.8% and 11% reported by 
McCellan et al.15 in the USA and Kissmeyer et al.16 in the UK respectively. 
The latter studies similarly used microalbuminuria as the marker of 
kidney damage. A relatively higher prevalence of 19.9% was reported 
by Abioye-Kuteyi et al.7 among rural dwellers and 45.5% was reported 
by Nwankwo et al.8 The occurrence of endemic urinary tract diseases 
may explain the relatively high prevalence of chronic kidney disease 
among the rural dwellers in the study by Abioye-Kuteyi et al., while the 
very high prevalence reported by Nwankwo et al. may be because the 
study was conducted among highly selected hypertensive patients who 
were more likely to have end-organ damage than patients attending a 
Table II: Distribution of study subjects by estimated GFR at the beginning 
of the study
Estimated GFR at the 
beginning of the study
Estimated GFR at three 
months 
Freq % Freq %
CKD present
(GFR < 60)   51 20.4 26 50.9
CKD absent
(GFR > 60)  199 79.6 25 49.1
Total  250 100.0 51 100.0
Table III: Distribution of subjects with persistent low GFR by persistent 
abnormal ACR 
Abnormal ACR Normal ACR Total
CKD present  
(GFR < 60) 22(61.1) 4(26.7) 26
CKD absent  
(GFR > 60) 14(38.9) 11(73.3) 25
Total 36(100.0) 15(100.0) 51
 χ² = 3.749, df = 1, p = 0.053*, * = Yates’ correction applied
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Table V: Linear regression of significant factors for abnormal ACR in the 
study subjects
Beta coefficient T Significance
Habitual analgesic intake 0.193 3.088 0.002
Age group 0.150 2.227 0.027
Habitual herbal consumption 0.093 1.515 0.131
Waist-hip ratio -0.094 -1.398 0.163
Diastolic BP 0.044 0.0386 0.700
Diabetes mellitus 0.056 0.903 0.177
Systolic BP 0.152 1.290 0.1988
Key: The beta coefficient is obtained by transforming the dependent and independent variables to standard 
(Z scores) before running the regression. It eliminates all units so that all variables can be compared 
directly. T represents ‘t statistics’, which determines the relative importance of each variable.
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family practice. Nevertheless, the prevalence of persistent albuminuria 
in this study and its implications for health make an urgent intervention 
imperative. Regular albuminuria screening not only allows the trends in 
individuals and communities to be monitored, but also forms the basis 
for a secondary renal prevention strategy.
The composition of the study population, by virtue of the genetic 
similarities to African-Americans, may partly explain the high prevalence 
of impaired kidney function obtained in this study.17 The study 
population was made up of black indigenous people from Nigeria. The 
predisposition of the black race to chronic kidney disease has been 
reported by several authors.18,19 The results of the third National Health 
and Nutrition Examination Survey (NHANES III) indicated that the African-
American has a substantially higher risk of chronic kidney disease than 
his white American counterpart.19 Contributory factors to the racial 
or ethnic disparity in the prevalence of CKD are best understood as a 
complex interaction between socio-cultural, genetic and environmental 
factors.20 Socioeconomic factors, such as poverty and a low income, with 
the consequent limited access to health care, and poor urban housing 
have also been reported to contribute to the incidence and prevalence of 
chronic kidney disease.21
The findings of this study show that the majority of subjects with 
persistent low GFR had persistent abnormal ACR, though the difference 
was not statistically significant. This finding suggests that subjects who 
have persistent low GFR are likely to have persistent albuminuria, which 
is indicative of progressive renal disease. This phenomenon underscores 
the importance of incidental albuminuria screening for renal disease, 
especially in the study of unselected family practice patients. It becomes 
relevant because CKD has a long, silent but progressive course that 
may be masked by other conditions, such that only purposive screening 
can ensure early detection and the opportunity to improve the patients’ 
outcome.22
This study found a significant association between increasing age and 
CKD. This is consistent with findings from other studies. Mulder et al. 
reported a substantial reduction in kidney function with ageing.23 It was 
earlier elucidated by Rowe et al. that kidney function declines naturally 
with increasing age.24 As CKD was commoner in subjects older than 
55 years, the recommendation to screen people in this age group is an 
important strategy for the detection of chronic kidney disease.
As expected, there was a significant association between CKD and a 
history of hypertension in the subjects in this study. Similar associations 
were found between elevated systolic and diastolic blood pressures. This 
corresponds with the findings of several studies. Chadban et al. reported 
that the prevalence of kidney disease was fivefold greater among 
patients with high blood pressure compared with normotensives.25 This 
is attributed to the early development of end-organ damage and late 
presentation for medical care in patients with hypertension. Nwankwo 
et al. also pointed to growing evidence for the existence of genetically 
determined and environmentally induced factors responsible for a higher 
risk of damage to the kidneys, especially in developing countries like 
Nigeria.26  
Similarly, a significant positive association was found between CKD 
and a history of diabetes mellitus in the study subjects. Chadban et al. 
reported that the prevalence of kidney disease was three times higher in 
those with diabetes mellitus than in those without diabetes mellitus.25 
The reasons cited for this trend include an increase in the prevalence of 
diabetes in the population and improved survival of patients with type 2 
diabetes mellitus. A similar trend of increasing prevalence of diabetes 
mellitus has also been reported from Nigeria by Alebiosu et al.27 Changes 
in lifestyle brought about by urbanisation and modernisation, as well as 
genetic factors, were cited as the perpetuating factors in the increasing 
prevalence of DM.28 In Nigeria, the rapid increase in type 2 diabetes 
mellitus is implicated as a major contributor to the rising incidence of 
CKD in recent years.28 
An abnormal waist-to-hip ratio but not BMI was found to be significantly 
associated with CKD in this study. This agrees with the findings of 
studies supporting waist-hip ratio or waist circumference as a better 
cardiovascular risk predictor than BMI.29 This is because waist-hip ratio 
is a measure of the relative accumulation of abdominal fat, while waist 
circumference is a measure of absolute abdominal fat as well as total 
body weight. The adoption of western diets has been identified as being 
responsible for the emerging trend of obesity in developing countries 
like Nigeria, and obesity is an important acquired risk factor in the 
development of type 2 diabetes mellitus, which consequently increases 
the burden of CKD.29
The findings of this study showed a strong association between CKD 
and habitual analgesic intake. Various authors have cited the habitual 
consumption of analgesics or analgesic abuse as contributing to the 
increasing prevalence of chronic renal disease in Nigerian communities.13,30 
However, the association in this study may be explained by the likelihood 
of other risk factors, like hypertension or diabetes mellitus, which may 
act in concert with analgesic abuse to cause albuminuria.
Similar reasons may explain the significant positive association found 
between CKD and habitual herbal ingestion in this study. The unbridled 
proliferation of herbal practitioners has led to the sale and consumptions 
of herbal products that have potential nephrotoxic effects, and this 
has been implicated in the increasing prevalence of end-stage renal 
disease.13,21
Alcohol consumption was not found to be a risk factor for CKD in this 
study. This is in agreement with the findings of Vupputuri and Sandler, 
who reported finding no significant association with alcohol consumption 
in a study examining the effects of lifestyle on the development of CKD.31 
Similarly, Stengel et al. reported that alcohol consumption was not 
associated with CKD in a non-concurrent cohort study of 9 082 adults.30
In this study, tobacco smoking was not associated with CKD, in contrast 
with findings that identified smoking as a major cardiovascular risk factor 
that promotes the progression of kidney disease.30 Tobacco smoking is 
perceived in Nigerian communities as an antisocial habit with which 
the subjects possibly may not want to be identified. This may explain 
the high negative response rate for tobacco smoking among the study 
subjects.
Gender differences did not have a significant association with CKD in 
this study. This does not agree with the findings of many other studies, in 
which the male gender was reported to be a non-modifiable risk factor 
for CKD.30,32 A possible reason for the lack of association may be due to 
the higher proportion of females than males in this study. 
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Unlike earlier studies that reported an association between CKD and 
a family history of hypertension and diabetes mellitus,25,33 no such 
association was found in this study. This may be due to a high negative 
response rate arising from the subjects having inadequate health 
information about their families.
This study also demonstrated that urgent attention needs to be paid to 
the risk factors for chronic kidney disease and to instituting interventions 
to slow the progression of renal disease. This need is driven by the high 
prevalence of persistent albuminuria and low GFR found in this study, 
and the possibility of using family practice clinics to identify people who 
may be at risk of CKD. 
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